🚀 VC round data is live in beta, check it out!
Redwood Scientific Technologies Valuation Multiples
Discover revenue and EBITDA valuation multiples for Redwood Scientific Technologies and similar public comparables like Neovacs, Itoco, DanCann Pharma, Lipigon Pharmaceuticals and more.
Redwood Scientific Technologies Overview
About Redwood Scientific Technologies
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products to market for stopping the addiction to nicotine.
Founded
1986
HQ
Employees
3
Website
Sectors
Financials (FY)
EV
$20K
Redwood Scientific Technologies Financials
Redwood Scientific Technologies reported last fiscal year revenue of — and negative EBITDA of ($3M).
In the same fiscal year, Redwood Scientific Technologies generated ($3M) in EBITDA losses and had net loss of ($3M).
Redwood Scientific Technologies P&L
In the most recent fiscal year, Redwood Scientific Technologies reported revenue of — and EBITDA of ($3M).
Redwood Scientific Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($3M) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($3M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Redwood Scientific Technologies Stock Performance
Redwood Scientific Technologies has current market cap of $20K, and enterprise value of $20K.
Market Cap Evolution
Redwood Scientific Technologies' stock price is $0.00.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $20K | $20K | 0.0% | XXX | XXX | XXX | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRedwood Scientific Technologies Valuation Multiples
Redwood Scientific Technologies trades at (0.0x) EV/EBITDA.
Redwood Scientific Technologies Financial Valuation Multiples
As of April 24, 2026, Redwood Scientific Technologies has market cap of $20K and EV of $20K.
Equity research analysts estimate Redwood Scientific Technologies' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Redwood Scientific Technologies has a P/E ratio of (0.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $20K | XXX | $20K | XXX | XXX | XXX |
| EV (current) | $20K | XXX | $20K | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (0.0x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (0.0x) | XXX | XXX | XXX |
| P/E | — | XXX | (0.0x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (0.0x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Redwood Scientific Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Redwood Scientific Technologies Margins & Growth Rates
Redwood Scientific Technologies' revenue in the last fiscal year grew by —.
Redwood Scientific Technologies' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.2M for the same period.
Redwood Scientific Technologies Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $1.2M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Redwood Scientific Technologies Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Redwood Scientific Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| Neovacs | XXX | XXX | XXX | XXX | XXX | XXX |
| Itoco | XXX | XXX | XXX | XXX | XXX | XXX |
| DanCann Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Lipigon Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| Stayble Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Redwood Scientific Technologies M&A Activity
Redwood Scientific Technologies acquired XXX companies to date.
Last acquisition by Redwood Scientific Technologies was on XXXXXXXX, XXXXX. Redwood Scientific Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Redwood Scientific Technologies
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialRedwood Scientific Technologies Investment Activity
Redwood Scientific Technologies invested in XXX companies to date.
Redwood Scientific Technologies made its latest investment on XXXXXXXX, XXXXX. Redwood Scientific Technologies invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Redwood Scientific Technologies
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Redwood Scientific Technologies
| When was Redwood Scientific Technologies founded? | Redwood Scientific Technologies was founded in 1986. |
| Where is Redwood Scientific Technologies headquartered? | Redwood Scientific Technologies is headquartered in United States. |
| How many employees does Redwood Scientific Technologies have? | As of today, Redwood Scientific Technologies has over 3 employees. |
| Is Redwood Scientific Technologies publicly listed? | Yes, Redwood Scientific Technologies is a public company listed on OTC Pink Sheets. |
| What is the stock symbol of Redwood Scientific Technologies? | Redwood Scientific Technologies trades under RSCI ticker. |
| Who are competitors of Redwood Scientific Technologies? | Redwood Scientific Technologies main competitors are Neovacs, Itoco, DanCann Pharma, Lipigon Pharmaceuticals. |
| What is the current market cap of Redwood Scientific Technologies? | Redwood Scientific Technologies' current market cap is $20K. |
| Is Redwood Scientific Technologies profitable? | No, Redwood Scientific Technologies is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.